Ju Yang

9.4k total citations · 1 hit paper
62 papers, 1.6k citations indexed

About

Ju Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ju Yang has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 11 papers in Surgery. Recurrent topics in Ju Yang's work include Gastric Cancer Management and Outcomes (6 papers), Palliative Care and End-of-Life Issues (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Ju Yang is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Palliative Care and End-of-Life Issues (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Ju Yang collaborates with scholars based in China, United States and Canada. Ju Yang's co-authors include Baorui Liu, Jing Yan, Francis Lau, Mary Lesperance, Michael Downing, Fanyan Meng, Jia Wei, Fangjun Chen, Xiaotong Chen and Hue Quan and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ju Yang

57 papers receiving 1.6k citations

Hit Papers

Targeting VEGF/VEGFR to Modulate Antitumor Immunity 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting VEGF/VEGFR to Modulate Antitumor Immunity
    2018 458 citations Ju Yang, Baorui Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju Yang China 17 761 510 499 248 175 62 1.6k
Faiz Anwer United States 23 1.1k 1.5× 782 1.5× 458 0.9× 164 0.7× 171 1.0× 328 2.5k
Alessandra Romano Italy 30 721 0.9× 890 1.7× 644 1.3× 162 0.7× 90 0.5× 187 2.6k
Bhagirathbhai Dholaria United States 24 1.6k 2.1× 718 1.4× 728 1.5× 226 0.9× 98 0.6× 139 2.5k
Xinwei Zhang China 19 696 0.9× 385 0.8× 239 0.5× 283 1.1× 64 0.4× 113 1.7k
Jinke Li China 13 537 0.7× 665 1.3× 401 0.8× 405 1.6× 169 1.0× 42 1.6k
Yi Chen China 22 531 0.7× 448 0.9× 341 0.7× 325 1.3× 55 0.3× 113 1.5k
Keisuke Watanabe Japan 22 1.1k 1.4× 607 1.2× 453 0.9× 214 0.9× 43 0.2× 125 2.2k
Hans Schlößer Germany 21 1.3k 1.7× 623 1.2× 924 1.9× 280 1.1× 51 0.3× 65 2.6k

Countries citing papers authored by Ju Yang

Since Specialization
Citations

This map shows the geographic impact of Ju Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Yang more than expected).

Fields of papers citing papers by Ju Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Yang. The network helps show where Ju Yang may publish in the future.

Co-authorship network of co-authors of Ju Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ju Yang. A scholar is included among the top collaborators of Ju Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju Yang. Ju Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Ju, Lixing Weng, Xiaohui Yang, et al.. (2025). Advances of Antimicrobial Peptides in the Treatment of Multidrug-Resistant Bacteria. BioDrugs. 39(6). 899–922.
3.
4.
Huang, Lixue, Xiaoying Gu, Yuanqi Wang, et al.. (2024). Performance of various pneumonia severity models for predicting adverse outcomes in elderly inpatients with community-acquired pneumonia. Clinical Microbiology and Infection. 30(11). 1426–1432. 8 indexed citations
5.
Wang, Han, Jiai Yan, Ju Yang, et al.. (2024). Gastrointestinal health and serum proteins are associated with BMD in postmenopausal women: a cross-sectional study. Nutrition & Metabolism. 21(1). 86–86. 2 indexed citations
6.
Liao, Yixuan, Ju Yang, He Wang, et al.. (2024). Respiratory medical quality control system construction in China. Aging Medicine. 7(5). 539–542. 1 indexed citations
7.
8.
9.
Tang, Jie, W. H. Tian, Shujie Huang, Ju Yang, & H. J. Yang. (2024). 760P Cadonilimab with neoadjuvant chemotherapy in advanced ovarian cancer patients (AK104-IIT-003): An open, prospective, single arm, phase II trial. Annals of Oncology. 35. S576–S576.
10.
11.
Ding, Naiqing, Qin Liu, Juan Du, et al.. (2023). Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma. Clinical & Translational Immunology. 12(9). e1467–e1467. 1 indexed citations
12.
Shi, Zhan, Ju Yang, Weiwei Kong, et al.. (2022). Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer. Frontiers in Oncology. 12. 782730–782730. 3 indexed citations
13.
Chen, Xiaotong, et al.. (2020). Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives. Theranostics. 10(13). 6011–6023. 71 indexed citations
14.
Ding, Naiqing, Zhengyun Zou, Huizi Sha, et al.. (2019). iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer. Nature Communications. 10(1). 1336–1336. 94 indexed citations
15.
16.
Yan, Jing, Ju Yang, Yang Yang, et al.. (2018). Use of Pulsed Low–Dose Rate Radiotherapy in Refractory Malignancies. Translational Oncology. 11(1). 175–181. 8 indexed citations
17.
18.
Yang, Ju, Jing Yan, & Baorui Liu. (2017). Targeting EGFRvIII for glioblastoma multiforme. Cancer Letters. 403. 224–230. 47 indexed citations
19.
Yaqoob, Usman, Sheng Cao, Uday Shergill, et al.. (2012). Neuropilin-1 Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor Microenvironment. Cancer Research. 72(16). 4047–4059. 105 indexed citations
20.
Lau, Francis, et al.. (2009). Using the Palliative Performance Scale to Provide Meaningful Survival Estimates. Journal of Pain and Symptom Management. 38(1). 134–144. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faiz Anwer Breakdown of academic impact, for papers by Alessandra Romano Breakdown of academic impact, for papers by Bhagirathbhai Dholaria Breakdown of academic impact, for papers by Xinwei Zhang Breakdown of academic impact, for papers by Jinke Li Breakdown of academic impact, for papers by Yi Chen Breakdown of academic impact, for papers by Keisuke Watanabe Breakdown of academic impact, for papers by Hans Schlößer
Rankless by CCL
2026